Invests in
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Lists including Peter
Investments
Gameto
Series B
Total Funding: $73M
SeLux Diagnostics
Series C
Total Funding: $120M
Freenome
Series B
Total Funding: $1.1B
NTx
Series B
Total Funding: $48M
TeraPore Technologies
Series A
Total Funding: $16M
Nimbus Therapeutics
Series Unknown
Total Funding: $640M
ARS Pharmaceuticals
Series D
Total Funding: $55M
Invivyd
Series C
Total Funding: $470M
Icosavax
Series B
Total Funding: $150M
Kinnate Biopharma
Series C
Total Funding: $200M
Work Experience
2001
Managing Partner
2001
RA Capital is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. Anyone wishing to discuss their business should not reach out through LinkedIn (I check my account rarely); please visit our firm's website for contact details and you will most certainly be routed to the right people.
2020
Steering Committee Member
2020
2009 - 2012
Board Member, Board on Global Science and Technology
2009 - 2012